3M Health Information Systems and IQMax expand deal: The companies plan to develop services that improve physician workflow, streamline revenue cycle processes, and provide instant access to critical information to support patient care. 3M branded mobile apps for charge capture and others that efficiently help physicians meet documentation requirements under ICD-10 will also come out of the newly expanded partnership. The apps will be for iPad, iPhone, Android, BlackBerry, and Windows Mobile. More

Mobile ultrasound startup Mobisante was spotlighted on CNN this past week: Here's the three-minute interview with Mobisante CEO and co-founder Sailesh Chultani:

7 NIH-funded studies for reducing young adult obesity rates: The National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) has funded seven clinical trials that make use of behavioral weight management programs, SMS, social networking, and Bluetooth-enabled scales in an effort to reduce obesity in the 18 - 35 year old population. Over the next five years the trials will receive $36 million (some of which comes from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.) More

Wireless Body platform expands to include temp sensing: PositiveID announced a deal with Spain-based RFID Solutions that results in the addition of a bio sensor for temperature to the company's Wireless Body platform: "The ability to continuously monitor a patient's vital signs provides a real-time gauge of their health and wellness," said Scott R. Silverman. "The addition of temperature-sensing capabilities to The Wireless Body platform is just one of many applications that we intend to provide for improved patient care." More

Wall Street Journal: Living alone can be dangerous to your health. Wireless health and other services are among the solutions offered. More

Myca inks a deal for e-prescribing: Myca Health has inked a deal with ZoomMed for ZRx Prescriber, a "web application that runs on a wireless device or computer that can be used by a prescriber for writing a prescription with embedded barcode." More

Echo Therapeutics received some ink in Diabetes Health magazine: "As the Prelude removes skin and hair that could interfere with the biosensor's reading, it passes tiny electric pulses into the skin. Based on the response to these pulses, the Prelude can determine when it has reached live underlying skin cells that allow the biosensor to provide a more accurate reading. The patient then applies the disk-shaped biosensor to the patch of skin prepped by the Prelude. The membrane on the biosensor's surface detects glucose as it diffuses out of the body's capillaries. The sensor contains an enzyme that reacts with the glucose and relays the indication as an electric signal. The impulse passes wirelessly to a handheld device, which records the information and monitors the readings. Each sensor can be used for two days before being replaced by a fresh one, and then either used in the same spot or another Prelude-treated location." More

8 reasons pharma should be interested in apps: Research2Guidance continues to leverage the data from its mHealth reports, this time with eight reasons pharma should care about smartphone apps: Potential reach, differentiation, improved outcomes, contemporary marketing, better understanding of adherence, improved costs, better physician relations, increased revenues. More